|
| Press Releases |
|
 |
|
| Wednesday, April 9, 2025 |
|
|
SinoMab BioScience Limited Breakthrough Phase 1b POC Results for SM17 in Atopic Dermatitis |
| SinoMab BioScience Limited (Stock Code: 3681.HK, "SinoMab" or the "Company"), is pleased to announce our breakthrough topline results from the completed Phase 1b clinical study evaluating SM17, a novel investigational therapy targeting the IL-25 (IL-17E) receptor pathway in moderate to severe atopic dermatitis (AD). more info >> |
|
| Tuesday, April 16, 2024 |
|
|
SinoMab BioScience preclinical results of SM17 on atopic dermatitis (AD) published on International Scientific Journal Allergy |
| SinoMab BioScience announced preclinical results of SM17 on atopic dermatitis (AD) published on International Scientific Journal Allergy. more info >> |
|
| Tuesday, September 12, 2023 |
|
|
SinoMab's IND Application of SM17 has once again Received Approval from NAMP |
| A Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialisation of therapeutics for the treatment of immunological diseases- SinoMab BioScience Limited (Stock Code: 3681.HK, "SinoMab" or the "Company") more info >> |
|
| Monday, August 14, 2023 |
|
|
SinoMab Announces that IND Application of SM17 for the Treatment of Asthma was Approved by NAMP |
| A Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases- SinoMab BioScience Limited (Stock Code: 3681.HK, "SinoMab" or the "Company") more info >> |
|
| Monday, June 12, 2023 |
|
|
SinoMab Submits another IND Application for SM17 for the Treatment of Atopic Dermatitis, Which was Accepted by NMPA CDE |
| A Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases - SinoMab BioScience Limited (Stock Code: 3681.HK, "SinoMab" or the "Company") more info >> |
|
| Monday, May 22, 2023 |
|
|
SinoMab Announces IND Application of SM17 for the Treatment of Asthma was Accepted by NMPA CDE |
| A Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases - SinoMab BioScience Limited (Stock Code: 3681.HK, "SinoMab" or the "Company") more info >> |
|
| Monday, December 19, 2022 |
|
|
SinoMab Awarded the "Most Valuable Pharmaceutical and Medical Company" in the Selection of the "7th Hong Kong Golden Stocks Awards" |
| SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases more info >> |
|
| Friday, November 4, 2022 |
|
|
SinoMab Announces Appointment of Mr. Shanchun WANG as the President (China) of the Company |
| SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases more info >> |
|
| Wednesday, August 24, 2022 |
|
|
Sinomab Announces IND Application of SN1011 for the Treatment of Neuromyelitis Optica Spectrum Disorder Approved by NMPA |
| SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases more info >> |
|
| Friday, July 8, 2022 |
|
|
SinoMab Received the Highest Subsidy from HKSTP |
| SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group", stock code: 3681.HK), a Hong Kong-listed biopharmaceutical company dedicated to the research, development more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
The All-American Koi Show 2026 - Experience the World's Top Koi Exhibition in Las Vegas, NV
Nov 5, 2025 01:30 HKT/SGT
|
|
|
NEC and Siemens collaborate to accelerate smart factory innovation
Nov 4, 2025 0:57 JST
|
|
|
Exhibiting at the Space Tech Expo Europe 2025 in Bremen, Germany
Nov 4, 2025 0:49 JST
|
|
|
Honda Announces Electric Motorcycle Business Brand Promise and Four Core Values
Nov 4, 2025 0:35 JST
|
|
|
Honda Unveils Its First Electric Motorcycle, the Honda WN7, at EICMA 2025
Nov 4, 2025 0:20 JST
|
|
|
Honda Unveils V3R 900 E-Compressor Prototype Equipped with V3 Engine with Electronically-controlled Compressor at EICMA 2025
Nov 4, 2025 0:00 JST
|
|
|
New GA-ASI Gambit 6 UCAV Adds Air-To-Ground Operations for International CCA
Nov 4, 2025 23:00 HKT/SGT
|
|
|
Honda Presents World Premiere of CB1000GT Sport Tourer at EICMA 2025
Nov 4, 2025 23:55 JST
|
|
|
New CB1000GT, global debut of Honda WN7 electric motorcycle, expansion of Honda E-Clutch line-up and V3R 900 E-Compressor Prototype lead Honda's EICMA 2025 line-up
Nov 4, 2025 23:40 JST
|
|
|
Honda Motorcycle Business Product Marks and New Emblem
Nov 4, 2025 23:21 JST
|
|
|
Military Metals Announces the Commencement of Resource Confirmation Drilling at the Flagship Trojarova Antimony Gold Project, European Union
Nov 4, 2025 20:39 HKT/SGT
|
|
|
From Hong Kong Airport to Hengqin: Chimelong Ferry Sets Sail for a Worry-Free Journey 
Nov 4, 2025 16:00 HKT/SGT
|
|
|
BlackBerry and Universiti Kebangsaan Malaysia Announce Strategic Partnership to Advance Malaysia's Future Cyber-Defenders and Embedded Software Talent
Nov 4, 2025 10:00 HKT/SGT
|
|
|
Developers bring home the gold from the 15th PropertyGuru Asia Property Awards (Singapore)
Nov 4, 2025 09:30 HKT/SGT
|
|
|
The Future of Autonomous Fighters Is Coming To Rome
Nov 4, 2025 07:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
